News Results

There are 646,427 News Results

Feb 18, 2021
IDACORP, Inc. Announces Fourth Quarter and Year-End 2020 Results, Initiates 2021 Earnings Guidance
IDACORP, Inc. (NYSE: IDA) reported fourth quarter 2020 net income attributable to IDACORP of $37.5 million, or $0.74 per diluted share, compared with $47.1 million, or $0.93 per diluted share,...
Feb 18, 2021
West Announces Fourth-Quarter and Full-Year 2020 Results
EXTON, Pa., Feb. 18, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter, full-year 2020 and introduced full-year 2021 financial guidance.
Feb 18, 2021
Astellas and Seagen Announce Submission of Two Supplemental Biologics License Applications to the U.S. FDA for PADCEV® (enfortumab vedotin-ejfv) in Locally Advanced or Metastatic Urothelial Cancer
TOKYO and BOTHELL, Wash., Feb. 18, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced completion of submissions...
Feb 18, 2021
Livent Releases Fourth Quarter And Full Year 2020 Results
PHILADELPHIA, Feb. 18, 2021 /PRNewswire/ --
Feb 19, 2021
SJW Group Announces 2020 Annual and Fourth Quarter Financial Results
SJW Group (NYSE: SJW) today reported financial results for the annual and fourth quarter ended December 31, 2020. Annual and Fourth Quarter Highlights “The challenges of 2020 were met head-on...
Feb 22, 2021
Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial Commitments
PITTSBURGH, Feb. 22, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced its 2021 financial guidance and reaffirmed its commitment to rapid de-leveraging, to enhancing and growing free cash flows,...
Feb 22, 2021
Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ(TM)) Improved Clinical, Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients
NORTH CHICAGO, Ill., Feb. 22, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that upadacitinib (45 mg, once daily) met the primary endpoint of clinical remission (per Adapted Mayo Score)...
Feb 23, 2021
Westlake Chemical Corporation Reports Fourth Quarter and Full Year 2020 Results
Westlake Chemical Corporation (NYSE: WLK) (the "Company" or "Westlake") today reported net income attributable to Westlake for the three months ended December 31, 2020 of $113 million, or $0.87 per...
Feb 23, 2021
EchoStar Announces Financial Results for Three and Twelve Months Ended December 31, 2020
ENGLEWOOD, Colo., Feb. 23, 2021 /PRNewswire/ -- EchoStar Corporation (NASDAQ: SATS) today announced its financial results for the three and twelve months ended December 31, 2020.
Feb 23, 2021
BioLineRx Reports Year-End 2020 Financial Results and Provides Corporate Update
TEL AVIV, Israel, Feb. 23, 2021 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the year...
64643

Pages

1

Stories of the day

Oct 9, 2025
Helsing acquires Blue Ocean, a specialist in autonomous underwater vehicles, to...
Oct 9, 2025
Viasat Awarded Contract by U.S. Space Force for Protected Tactical SATCOM-...
Oct 9, 2025
US Army Selects L3Harris to Support NGC2 Program
Oct 9, 2025
Damen Naval signs contract with Terma A/S for Decoy Launching System on...